Default Lot

This tender is for a framework agreement for the supply of immunosuppressive drugs, specifically OCRELIZUMABUM 920 MG. The agreement defines minimum and maximum quantities for both contract services (CS) and framework agreement (AC) orders. The minimum quantity for CS is 1 unit, and the maximum is 10 units. For AC orders, the minimum is 5 units, and the maximum is 400 units. The maximum value for a CS order is specified as 417,310.40 lei. This framework agreement aims to ensure a consistent and readily available supply of this critical medication for patients requiring immunosuppressive therapy. The structure allows for flexible ordering based on fluctuating patient needs while establishing clear limits and financial parameters. Bidders are expected to meet stringent quality and regulatory requirements for pharmaceutical products. The contract is essential for patient treatment continuity.

This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals. Located in Romania, Europe, this opportunity is open to firms and consortiums.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.